Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 278

1.

An economic evaluation of a perindopril-based blood pressure lowering regimen for patients who have suffered a cerebrovascular event.

Tavakoli M, Pumford N, Woodward M, Doney A, Chalmers J, MacMahon S, Macwalter R.

Eur J Health Econ. 2009 Feb;10(1):111-9. doi: 10.1007/s10198-008-0108-3. Epub 2008 Apr 30.

PMID:
18446392
2.
4.
5.

Economic evaluation of ASCOT-BPLA: antihypertensive treatment with an amlodipine-based regimen is cost effective compared with an atenolol-based regimen.

Lindgren P, Buxton M, Kahan T, Poulter NR, Dahlöf B, Sever PS, Wedel H, Jönsson B; ASCOT trial investigators..

Heart. 2008 Feb;94(2):e4. Epub 2007 Oct 4.

PMID:
17916665
7.

Cost-effectiveness of lowering blood pressure with a fixed combination of perindopril and indapamide in type 2 diabetes mellitus: an ADVANCE trial-based analysis.

Glasziou PP, Clarke P, Alexander J, Rajmokan M, Beller E, Woodward M, Chalmers J, Poulter N, Patel A.

Med J Aust. 2010 Sep 20;193(6):320-4.

PMID:
20854235
9.

Perindopril-based blood pressure lowering in individuals with cerebrovascular disease: consistency of benefits by age, sex and region.

Rodgers A, Chapman N, Woodward M, Liu LS, Colman S, Lee A, Chalmers J, MacMahon S; Perindopril Protection against Recurrent Stroke Study Collaborative Group..

J Hypertens. 2004 Mar;22(3):653-9.

PMID:
15076173
10.

Perindopril pROtection aGainst REcurrent Stroke Study (PROGRESS): interpretation and implementation.

Chalmers J, MacMahon S.

J Hypertens Suppl. 2003 Jun;21(5):S9-14.

PMID:
12953850
11.
12.

Trials on blood pressure-lowering and secondary stroke prevention.

Chalmers J.

Am J Cardiol. 2003 May 22;91(10A):3G-8G. Review.

PMID:
12781902
13.

Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease.

Tzourio C, Anderson C, Chapman N, Woodward M, Neal B, MacMahon S, Chalmers J; PROGRESS Collaborative Group..

Arch Intern Med. 2003 May 12;163(9):1069-75.

PMID:
12742805
14.
16.
17.

Cost effectiveness of perindopril in reducing cardiovascular events in patients with stable coronary artery disease using data from the EUROPA study.

Briggs A, Mihaylova B, Sculpher M, Hall A, Wolstenholme J, Simoons M, Deckers J, Ferrari R, Remme WJ, Bertrand M, Fox K; EUROPA Trial Investigators..

Heart. 2007 Sep;93(9):1081-6. Epub 2006 Nov 29.

18.
19.

PROGRESS (Perindopril Protection Against Recurrent Stroke Study): regional characteristics of the study population at baseline. PROGRESS Management Committee.

Chalmers J, Neal B, MacMahon S; PROGRESS Management Committee..

J Hypertens Suppl. 2000 May;18(1):S13-9.

PMID:
10939785

Supplemental Content

Support Center